Autopsy report · NCT02313012
Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors
Cause of deathNo reason given
Life of this trial
- Ran for about 1 year 4 months before it stopped.
- 19 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Celgene
- Sponsor type
- Industry
- Conditions
- Neoplasm Metastasis
- Interventions
- CC-90003
- Participants
- 19
- Sites
- 5
- Countries
- Australia, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.